R
RGEN
Repligen
173.88
+10.04+6.13%After Hours: 173.88 0.00 0.00%19:30 10/09 EDT
OPEN/PREV CLOSE172.51/172.51
TODAY RANGE169.73-177.96
VOL1.26M
MARKET CAP9.90B
52 WEEK RANGE100.99-198.87
AVG VOL (3M)1.21M
% TURNOVER1.76%
TURNOVER--
P/E (TTM)239.09
% RANGE4.77%
EPS(TTM)0.7337
P/E(FORWARD)232.35
P/B4.687
BVPS37.43
DIVIDEND--
P/S13.38
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.34B
SHARES OUTSTANDING56.44M
NEXT EARNINGS10/26-10/30
FREE FLOAT53.23M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·2d ago
Does Repligen (RGEN) Look Fully Valued After The BioLife Deal?
Seeking Alpha·4d ago
These healthcare stocks have the highest EPS revision grade ahead of Q3 results
Dow Jones·6d ago
Repligen Is Maintained at Overweight by Barclays
TipRanks·6d ago
Repligen price target raised to $225 from $175 at Barclays
Dow Jones·10/06 21:08
*News On BioLife Solutions Inc. (BLFS) Now Under RGEN
TipRanks·10/06 13:29
Repligen Completes BioLife Acquisition to Expand Cell Therapies
Dow Jones·10/06 13:05
*Repligen Completes Acquisition Of BioLife Solutions >RGEN
Dow Jones·10/06 13:05
Press Release: Repligen Completes Acquisition of BioLife Solutions
TipRanks·10/05 21:20
Freshworks to replace BioLife Solutions in S&P 600 at open on 10/8
Simply Wall St·10/01 21:17
Repligen (RGEN) Stock Looks Stretched After A 32% One Year Run
Seeking Alpha·10/01 16:01
William Blair refreshes its analyst conviction list
TipRanks·09/29 18:43
New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector
Same Industry
Name/Symbol
Change%
Price